Position in RPRX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$148,168,440
+$44,637,237 QoQ
Shares Held
3,088,773
+15.3% QoQ
Ownership
0.536%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Amundi holds $2,277,505,863 across 70 Biotechnology names. RPRX ranks #4 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,009,798 | $780,210,323 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,472,496 | $657,528,360 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
747,544 | $247,339,881 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
3,088,773 | $148,168,440 | |
| 5 | INSM |
INSMED Inc
|
804,977 | $131,629,838 | |
| 6 | INCY |
Incyte Corp
|
1,003,969 | $94,493,561 | |
| 7 | MRNA |
Moderna, Inc.
|
904,823 | $45,965,008 | |
| 8 | ARGX |
Argenx SE
|
61,433 | $44,861,448 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $148,168,440 | 3,088,773 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $103,531,203 | 2,679,379 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $73,029,070 | 2,069,985 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $100,792,879 | 2,797,471 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $38,519,572 | 1,237,378 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $65,152,484 | 2,553,998 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $104,425,600 | 3,691,255 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $54,431,949 | 2,064,162 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $67,070,773 | 2,208,455 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $103,733,444 | 3,692,896 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $43,751,168 | 1,612,055 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $42,185,112 | 1,372,320 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,207,636 | 1,032,685 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $33,843,658 | 856,368 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $5,292,044 | 133,908 | Principal | Defined | 2023-02-14 | |
| 2022-09-30 | $33,333,566 | 829,606 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $39,373,226 | 936,566 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $11,687,100 | 299,977 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,958,958 | 199,723 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $50,353,173 | 1,393,281 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $115,930,577 | 2,828,265 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||